CytomX Therapeutics Inc - CTMX - stock price prediction, stock price target, analyst ratings from 9 analysts

CytomX Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of -39.9%, and profit growth estimate of -114.1% for FY25, based on top 9 analyst calls.